5O
5AM Opportunities II (GP), LLC disclosed a 5.3% stake in ZNTL
5AM Opportunities II (GP), LLC reported owning 5.3% of Zentalis Pharmaceuticals, Inc. (ZNTL) (5,157,742 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G